Twist Bioscience Corporation (TWST)
Chart Events
Performance Outlook
| Previous Close | 142.06 |
| Open | 143.24 |
| Bid | 135.00 x 1000 |
| Ask | 143.00 x 800 |
| Day's Range | 133.54 - 143.24 |
| 52 Week Range | 25.72 - 214.07 |
| Volume | 411,153 |
| Avg. Volume | 1,048,113 |
| Market Cap | 6.579B |
| Beta (5Y Monthly) | 0.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.76 |
| Earnings Date | Feb 04, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 146.00 |
- Business Wire
Twist Bioscience to Expand Oregon Lease, Supporting Future Growth
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has exercised its right of first refusal to expand the lease for its "Factory of the Future" manufacturing facility near Portland, Oregon.
- Motley Fool
4 Cathie Wood Stocks That Could Deliver Bigger Gains Than Tesla
Everyone knows that ARK Invest CEO Cathie Wood is a huge fan of Tesla (NASDAQ: TSLA). In this Motley Fool Live video recorded on April 7, Motley Fool contributors Keith Speights and Brian Orelli identify four healthcare stocks that are among Wood's top holdings that just might deliver bigger gains than Tesla.
- Business Wire
Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a partnership with Pure Biologics to accelerate the discovery of immuno-oncology antibody-based drugs.
